Concepedia

Klaus Herrlinger

KH

Statistics

Publications

28

Citations

2.3K

H-Index

23

Active since

2001

Affiliations

Robert Bosch Hospital(Current)

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

University of Lübeck

University of Tübingen

University Hospital Schleswig-Holstein

Klaus Herrlinger is an author at Robert Bosch Hospital specializing in inflammatory bowel disease, gastrointestinal inflammation, and medicine.

Publications per year

2001–2021

28

Publications

28

Inducible and Constitutive β-Defensins Are Differentially Expressed in Crohn's Disease and Ulcerative Colitis

Jan Wehkamp, Michael Weichenthal, Oliver Mueller et al. · Inflammatory Bowel Diseases · 2003 · 291 citations

Life Sciences, Immunology, Microbiology +17

Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis

Michael Gersemann, Irmgard Kübler, Maureen J. Koslowski et al. · Differentiation · 2009 · 287 citations

Medicine, Immunology, Pathology +14

Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease

Jan Wehkamp, Klaus Fellermann, Klaus Herrlinger et al. · European Journal of Gastroenterology & Hepatology · 2002 · 199 citations

Life Sciences, Immunology, Molecular Biology +17

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Walter Reinisch, Sieglinde Angelberger, Wolfgang Petritsch et al. · Gut · 2010 · 172 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)

Klaus Fellermann, Zita Tanko, Klaus Herrlinger et al. · Inflammatory Bowel Diseases · 2002 · 161 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +13

1–5 of 28